Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439056
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-05-16
Brief Title:
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Sponsor:
Nanexa AB
Organization:
Nanexa AB